Proven Medical Device Executive to Lead Commercialization of Breakthrough Technology for Objective Identification of Concussion
October 23, 2014
Tucson, AZ – October 14, 2014 — BioDirection, Inc., an emerging medical device company focused on the development and commercialization of rapid, low-cost point-of-care devices for the early identification of mild traumatic brain injury (concussion) announced today that Eric B. Goorno has joined the Company as President & Chief Executive Officer. The new CEO will reside at the company’s headquarters in Massachusetts. Former CEO and Founder Brian McGlynn will transition to Director, Chief Technical Officer and Executive Vice President.
“Mr. Goorno is a proven medical device executive with more than twenty-five years of medical industry experience in both early stage and high growth healthcare companies across multiple disease states and medical specialties. He is an aggressive, results-driven leader with extensive experience in emerging businesses, manufacturing and industry leading organizations.” said Mr. McGlynn. “Eric’s leadership, hands-on management skills and diverse cross-functional background will ensure that we are positioned to launch the first objective point-of-care product into the market.”
Prior to joining BioDirection, Eric had an extensive career with Boston Scientific (BSC), most recently as President of the firm’s $395 million Urology & Gynecology Division where he was responsible for establishing and driving the division’s global strategy and remarkable sustained growth. Prior to assuming this role, Eric held positions as Vice President, New Market Development and Strategic Planning, Urology & Gynecology; Vice President of Operations, Microwave Divisions; and Vice President and General Manager, Symbiosis Division. After leaving Boston Scientific in 2009, he founded Pulse Veterinary Technologies, L.L.C. where he served as Founder and CEO until moving to BioDirection. Earlier in his distinguished career Eric held various plant manager and operation roles at Synthes USA. Goorno holds a Bachelor of Arts Degree from Tufts University, cum laude, in Political Science and a Master of Business Administration Degree from Harvard Graduate School of Business Administration.
BioDirection, Inc. is a privately-held medical device company focused on the design, development and commercialization of easy-to-use, low cost and portable point-of-care biomarker devices for screening and monitoring of acquired brain injury. The company's strategy is to blend proven science with innovative technology to create diagnostic tools to address critical market needs. For more information, visit http://www.biodirection.com.
James A. Wylie, 203-240-1319
BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.